SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Abbott Says SonicForce Trial Meets Safety and Effectiveness Endpoints

Abbott said its experimental SonicForce device trial met its primary safety and effectiveness endpoints.

ABT

Story updates

09:53:24 AM UTC
SquawkNews
Abbott Laboratories reported 30-day results from the 335-patient TECTONIC CAD study evaluating its i

Related stories